Peter Hanns Zobel never planned a career as hotelier.
With his doctoral degree in pharmaceutical technology and executive positions at drug research giants such as Merck KGaA, Novartis Pharma and Horizon Pharma Inc., he seems ill-suited to be choosing furnishings and fixtures for a five-star hotel.
Yet here he is proudly leading tours through the futuristic, elliptically shaped new building that will open this fall on the 25,000-meter campus of the Innovation and Start-Up Center for Biotechnology, known by its German acronym, IZB, in Martinsried near Munich.
“The business model of running a hotel is new to us,” said Mr. Zobel, IZB chief executive officer. “This is really entering new territory.”